Emergent BioSolutions, Inc.

2273 Research Blvd., Suite 400
Rockville, MD 20850

About Emergent BioSolutions, Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission – to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. Our marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Our commercial business focuses on immunobiotics for use against infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs.

Competitors of Emergent BioSolutions, Inc.

Catalent offers a full range of development services, such as pre-clinical support, API development, analytical services, drug delivery development, clinical manufacturing and packaging services. We have expertise in inhalation development, and can offer innovative biologic cell-line development... Read More

Mycoscience Labs

Edge Pharma

Edge Pharma is a pharmaceutical sterile and non-sterile 503B Outsourcing Facility offering high quality, innovative solutions for the health care community. Edge Pharma adheres to the values put forth by USP 795, 797, 800, and CGMP. Through this our customers have the confidence in us to deliver... Read More